GTBPVSVHC• 6 Months (Normalized)
GTBP vs VHC (GT Biopharma Inc. vs VirnetX Holding Corp)
Showing Closing Date Range from Apr 5 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+1270.79%
GT Biopharma Inc.
Normalized Baseline0.00%
VHC Performance $10.48
-28.37%
VirnetX Holding Corp
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1299.16 pts
GTBP outperforming by 1299.16 percentage points
GTBPVHC
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP VHC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GTBP Price | GTBP Gain (%) | VHC Price | VHC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +1270.79% | $10.48 | -28.37% | +1299.16% |
| Sep 30, 2026 | $- | $10.19 | -30.35% | - | |
| Sep 29, 2026 | $6.88 | +1444.94% | $- | - | |
| Sep 28, 2026 | $6.80 | +1428.09% | $10.23 | -30.08% | +1458.17% |
| Sep 25, 2026 | $6.89 | +1448.31% | $10.36 | -29.19% | +1477.50% |
| Sep 24, 2026 | $6.83 | +1434.83% | $12.23 | -16.40% | +1451.23% |
| Sep 23, 2026 | $7.10 | +1495.51% | $12.65 | -13.53% | +1509.04% |
| Sep 21, 2026 | $7.18 | +1513.48% | $12.95 | -11.48% | +1524.96% |
| Sep 18, 2026 | $7.16 | +1508.99% | $12.00 | -17.98% | +1526.97% |
| Sep 17, 2026 | $7.49 | +1583.15% | $11.73 | -19.82% | +1602.97% |
| Sep 16, 2026 | $7.81 | +1655.06% | $11.57 | -20.92% | +1675.98% |
| Sep 15, 2026 | $9.00 | +1922.47% | $11.27 | -22.97% | +1945.44% |
| Sep 14, 2026 | $11.63 | +2513.48% | $11.07 | -24.33% | +2537.81% |
| Sep 11, 2026 | $8.61 | +1834.83% | $11.50 | -21.39% | +1856.22% |
| Sep 10, 2026 | $6.18 | +1288.76% | $11.57 | -20.92% | +1309.68% |
Page 1 of 9